Skip to main content

Chronic obstructive pulmonary disease in Brazil: mortality and hospitalization trends and rates, 1996–2008

Buy Article:

$34.78 + tax (Refund Policy)

SETTING: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death among adults in Brazil.

OBJECTIVE: To evaluate the mortality and hospitalisation trends in Brazil caused by COPD during the period 1996–2008.

DESIGN: We used the health official statistics system to obtain data about mortality (1996–2008) and morbidity (1998–2008) due to COPD and all respiratory diseases (tuberculosis: codes A15–16; lung cancer: code C34, and all diseases coded from J40 to 47 in the 10th Revision of the International Classification of Diseases) as the underlying cause, in persons aged 45–74 years. We used the Joinpoint Regression Program log-linear model using Poisson regression that creates a Monte Carlo permutation test to identify points where trend lines change significantly in magnitude/direction to verify peaks and trends.

RESULTS: The annual per cent change in age-adjusted death rates due to COPD declined by 2.7% in men (95%CI −3.6 to −1.8) and −2.0% (95%CI −2.9 to −1.0) in women; and due to all respiratory causes it declined by −1.7% (95%CI 2.4 to −1.0) in men and −1.1% (95%CI −1.8 to −0.3) in women. Although hospitalisation rates for COPD are declining, the hospital admission fatality rate increased in both sexes.

CONCLUSION: COPD is still a leading cause of mortality in Brazil despite the observed decline in the mortality/hospitalisation rates for both sexes.

Keywords: Brazil; COPD; epidemiology; hospitalisation; mortality

Document Type: Regular Paper

Affiliations: 1: Hospital Universitário, University of São Paulo, Sao Paulo, Sao Paulo, Brazil; and Universidade Federal do Amazonas, Coari, Amazonas, Brazil 2: School of Medicine, University of São Paulo, Sao Paulo, Sao Paulo, Brazil; and Hospital Universitário, University of São Paulo, Sao Paulo, Sao Paulo, Brazil

Publication date: 01 March 2011

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content